BiomeNrich POST M005™
– The First Akkermansia-Based Solution to Receive NDIN Acknowledgement
BiomeNrich™ POST M005 is the world's first Akkermansia-based solution to receive NDIN acknowledgment from the U.S. FDA, marking a major milestone in microbiome innovation. Backed by extensive clinical research, POST M005™ is a next-generation postbiotic solution designed to promote muscle health.
Unlike probiotics, postbiotics like POST M005™ offer greater stability, making them suitable for diverse applications in the health and wellness industry.
Figure 1. Manufacturing Process of POST M005™
Clinical studies have demonstrated POST M005™’s efficacy in supporting muscle health, with results published in a peer-reviewed journal.10
Key findings include:
✔ 130% increase in follistatin, a protein that promotes muscle synthesis
✔ 200% increase in leg strength (compared to placebo group)
Building the Future Together
The Healthy Aging market is growing rapidly, with Muscle Health and Microbiome Solutions leading the demand. This presents a unique opportunity to differentiate your brand's portfolio by integrating POST M005™—the first Akkermansia-based solution to receive NDIN acknowledgment.
Seize this opportunity to bring an innovative muscle health solution to the market.
Contact us today to explore collaboration opportunities and request samples of M005™.
Learn more →